Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

CPMP approves saquinavir for marketing

July 5, 1996

HIV protease inhibitors reported by Pharmacia & Upjohn

July 5, 1996

Glaxo Wellcome, Vertex license anti-HIV patents from Searle

July 5, 1996

Second receptor for HIV infection reported

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

U.S. development of DS-4152 for Kaposi's sarcoma treatment discontinued

June 28, 1996

Sequus' Caelyx approved by European Commission

June 28, 1996

Hybridon's GEM-132 to undergo clinical trials

June 28, 1996

Remune covered under Finnish patent

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...